Black Diamond Therapeutics (BDTX) EPS (Basic): 2018-2021
Historic EPS (Basic) for Black Diamond Therapeutics (BDTX) over the last 4 years, with Dec 2021 value amounting to -$3.47.
- Black Diamond Therapeutics' EPS (Basic) fell 12.70% to -$0.71 in Q4 2021 from the same period last year, while for Dec 2021 it was -$3.15, marking a year-over-year decrease of 53.66%. This contributed to the annual value of -$3.47 for FY2021, which is 69.27% down from last year.
- Black Diamond Therapeutics' EPS (Basic) amounted to -$3.47 in FY2021, which was down 69.27% from -$2.05 recorded in FY2020.
- In the past 5 years, Black Diamond Therapeutics' EPS (Basic) ranged from a high of -$2.05 in FY2020 and a low of -$16.99 during FY2019.
- Its 3-year average for EPS (Basic) is -$7.50, with a median of -$3.47 in 2021.
- As far as peak fluctuations go, Black Diamond Therapeutics' EPS (Basic) slumped by 284.39% in 2019, and later soared by 87.93% in 2020.
- Black Diamond Therapeutics' EPS (Basic) (Yearly) stood at -$4.42 in 2018, then plummeted by 284.39% to -$16.99 in 2019, then skyrocketed by 87.93% to -$2.05 in 2020, then plummeted by 69.27% to -$3.47 in 2021.